Therefore, we aimed to describe the prevalence of AAA1 IgGs in a large pediatric sample, and to determine whether a SARS-CoV-2-induced AAA1 response could be associated with persisting COVID-19 symptoms up to three months after infection using standardized questionnaires. The gene discussed is NPSR1-AS1; the disease is COVID-19.